View in EDS HTML Full Text PDF Full Text

Brain radiotoxicity-related 15CAcBRT gene expression signature predicts survival prognosis of glioblastoma patients.

Saved in:
Bibliographic Details
Title: Brain radiotoxicity-related 15CAcBRT gene expression signature predicts survival prognosis of glioblastoma patients.
Authors: Reyes-González J; Precision Translational Oncology Laboratory, National Institute of Genomic Medicine, Mexico City, Mexico., Barajas-Olmos F; Immunogenomics and Metabolic Diseases Laboratory, National Institute of Genomic Medicine, Mexico City, Mexico., García-Ortiz H; Immunogenomics and Metabolic Diseases Laboratory, National Institute of Genomic Medicine, Mexico City, Mexico., Magraner-Pardo L; Gene Function Team, The Institute of Cancer Research (ICR), London, UK., Pons T; Department of Immunology and Oncology, National Center for Biotechnology, Spanish National Research Council (CNB-CSIC), Madrid, Spain., Moreno S; Radioneurosurgery Unit, National Institute of Neurology and Neurosurgery; Mexico City, Mexico., Aguirre-Cruz L; Neuroendocrinology Laboratory, National Institute of Neurology and Neurosurgery; Mexico City, Mexico., Reyes-Abrahantes A; Precision Translational Oncology Laboratory, National Institute of Genomic Medicine, Mexico City, Mexico., Martínez-Hernández A; Immunogenomics and Metabolic Diseases Laboratory, National Institute of Genomic Medicine, Mexico City, Mexico., Contreras-Cubas C; Immunogenomics and Metabolic Diseases Laboratory, National Institute of Genomic Medicine, Mexico City, Mexico., Barrios-Payan J; Department of Pathology, National Institute of Medical Sciences and Nutrition Salvador Zubiran, Mexico City, Mexico., Ruiz-Garcia H; Department of Neurosurgery and Brain Tumor Stem Cell Research Laboratory, Mayo Clinic, Jacksonville, Florida,USA., Hernandez-Pando R; Department of Pathology, National Institute of Medical Sciences and Nutrition Salvador Zubiran, Mexico City, Mexico., Quiñones-Hinojosa A; Department of Neurosurgery and Brain Tumor Stem Cell Research Laboratory, Mayo Clinic, Jacksonville, Florida,USA., Orozco L; Immunogenomics and Metabolic Diseases Laboratory, National Institute of Genomic Medicine, Mexico City, Mexico., Abrahantes-Pérez MDC; Precision Translational Oncology Laboratory, National Institute of Genomic Medicine, Mexico City, Mexico.
Source: Neuro-oncology [Neuro Oncol] 2023 Feb 14; Vol. 25 (2), pp. 303-314.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35802478
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Brain radiotoxicity-related 15CAcBRT gene expression signature predicts survival prognosis of glioblastoma patients.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Reyes-González+J%22">Reyes-González J</searchLink>; Precision Translational Oncology Laboratory, National Institute of Genomic Medicine, Mexico City, Mexico.<br /><searchLink fieldCode="AU" term="%22Barajas-Olmos+F%22">Barajas-Olmos F</searchLink>; Immunogenomics and Metabolic Diseases Laboratory, National Institute of Genomic Medicine, Mexico City, Mexico.<br /><searchLink fieldCode="AU" term="%22García-Ortiz+H%22">García-Ortiz H</searchLink>; Immunogenomics and Metabolic Diseases Laboratory, National Institute of Genomic Medicine, Mexico City, Mexico.<br /><searchLink fieldCode="AU" term="%22Magraner-Pardo+L%22">Magraner-Pardo L</searchLink>; Gene Function Team, The Institute of Cancer Research (ICR), London, UK.<br /><searchLink fieldCode="AU" term="%22Pons+T%22">Pons T</searchLink>; Department of Immunology and Oncology, National Center for Biotechnology, Spanish National Research Council (CNB-CSIC), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Moreno+S%22">Moreno S</searchLink>; Radioneurosurgery Unit, National Institute of Neurology and Neurosurgery; Mexico City, Mexico.<br /><searchLink fieldCode="AU" term="%22Aguirre-Cruz+L%22">Aguirre-Cruz L</searchLink>; Neuroendocrinology Laboratory, National Institute of Neurology and Neurosurgery; Mexico City, Mexico.<br /><searchLink fieldCode="AU" term="%22Reyes-Abrahantes+A%22">Reyes-Abrahantes A</searchLink>; Precision Translational Oncology Laboratory, National Institute of Genomic Medicine, Mexico City, Mexico.<br /><searchLink fieldCode="AU" term="%22Martínez-Hernández+A%22">Martínez-Hernández A</searchLink>; Immunogenomics and Metabolic Diseases Laboratory, National Institute of Genomic Medicine, Mexico City, Mexico.<br /><searchLink fieldCode="AU" term="%22Contreras-Cubas+C%22">Contreras-Cubas C</searchLink>; Immunogenomics and Metabolic Diseases Laboratory, National Institute of Genomic Medicine, Mexico City, Mexico.<br /><searchLink fieldCode="AU" term="%22Barrios-Payan+J%22">Barrios-Payan J</searchLink>; Department of Pathology, National Institute of Medical Sciences and Nutrition Salvador Zubiran, Mexico City, Mexico.<br /><searchLink fieldCode="AU" term="%22Ruiz-Garcia+H%22">Ruiz-Garcia H</searchLink>; Department of Neurosurgery and Brain Tumor Stem Cell Research Laboratory, Mayo Clinic, Jacksonville, Florida,USA.<br /><searchLink fieldCode="AU" term="%22Hernandez-Pando+R%22">Hernandez-Pando R</searchLink>; Department of Pathology, National Institute of Medical Sciences and Nutrition Salvador Zubiran, Mexico City, Mexico.<br /><searchLink fieldCode="AU" term="%22Quiñones-Hinojosa+A%22">Quiñones-Hinojosa A</searchLink>; Department of Neurosurgery and Brain Tumor Stem Cell Research Laboratory, Mayo Clinic, Jacksonville, Florida,USA.<br /><searchLink fieldCode="AU" term="%22Orozco+L%22">Orozco L</searchLink>; Immunogenomics and Metabolic Diseases Laboratory, National Institute of Genomic Medicine, Mexico City, Mexico.<br /><searchLink fieldCode="AU" term="%22Abrahantes-Pérez+MDC%22">Abrahantes-Pérez MDC</searchLink>; Precision Translational Oncology Laboratory, National Institute of Genomic Medicine, Mexico City, Mexico.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100887420%22">Neuro-oncology</searchLink> [Neuro Oncol] 2023 Feb 14; Vol. 25 (2), pp. 303-314.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100887420 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1523-5866 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215228517%22">15228517 </searchLink><i>NLM ISO Abbreviation: </i>Neuro Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35802478
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/neuonc/noac171
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 303
    Titles:
      – TitleFull: Brain radiotoxicity-related 15CAcBRT gene expression signature predicts survival prognosis of glioblastoma patients.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Reyes-González J
      – PersonEntity:
          Name:
            NameFull: Barajas-Olmos F
      – PersonEntity:
          Name:
            NameFull: García-Ortiz H
      – PersonEntity:
          Name:
            NameFull: Magraner-Pardo L
      – PersonEntity:
          Name:
            NameFull: Pons T
      – PersonEntity:
          Name:
            NameFull: Moreno S
      – PersonEntity:
          Name:
            NameFull: Aguirre-Cruz L
      – PersonEntity:
          Name:
            NameFull: Reyes-Abrahantes A
      – PersonEntity:
          Name:
            NameFull: Martínez-Hernández A
      – PersonEntity:
          Name:
            NameFull: Contreras-Cubas C
      – PersonEntity:
          Name:
            NameFull: Barrios-Payan J
      – PersonEntity:
          Name:
            NameFull: Ruiz-Garcia H
      – PersonEntity:
          Name:
            NameFull: Hernandez-Pando R
      – PersonEntity:
          Name:
            NameFull: Quiñones-Hinojosa A
      – PersonEntity:
          Name:
            NameFull: Orozco L
      – PersonEntity:
          Name:
            NameFull: Abrahantes-Pérez MDC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 14
              M: 02
              Text: 2023 Feb 14
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1523-5866
          Numbering:
            – Type: volume
              Value: 25
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Neuro-oncology
              Type: main
ResultId 1